Cargando…
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
SIMPLE SUMMARY: Ovarian cancer (OvCa) is a prominent cause of cancer death in women due to missed early signs and late diagnoses. Once a woman is diagnosed with OvCa, the standard treatment is surgery to remove the tumor, followed by chemotherapy. Many women go into remission after treatment, but th...
Autores principales: | McFadden, Melayshia, Singh, Santosh Kumar, Oprea-Ilies, Gabriela, Singh, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582784/ https://www.ncbi.nlm.nih.gov/pubmed/34771642 http://dx.doi.org/10.3390/cancers13215480 |
Ejemplares similares
-
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer
por: McFadden, Melayshia, et al.
Publicado: (2023) -
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023) -
Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2021) -
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021) -
Drug delivery approaches for breast cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2017)